Saroglitazar

Primary biliary cholangitis

Manufacturer: Zydus Therapeutics
Regulatory submission: NDA submitted by May 2026
Launch: Anticipated in April 2027, the start of Zydus fiscal year 2028
Last updated: September 19, 2026

Section

Product information and disease description Product description Product information

Drug/Drug, drug/disease interactions

1 evidence topic · 1 source

Effects of other drugs on Saroglitazar

No evidence found.